🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This study involves the use of an investigational drug called NGP 555. In e...
Status
Completed
Location
WCCT Global
Start Date
2016-01
Trial ID
NCT02537938
Treatments Being Tested
The purpose of the study is to evaluate the safety and tolerability of sing...
Status
Completed
Location
SGS Stuivenberg
Start Date
2009-12
Trial ID
NCT01023321
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
To Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics o...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2024-04-10
Trial ID
NCT06344533
Treatments Being Tested
This is a Phase 1, randomized, double-blinded, placebo-controlled, single a...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2025-03-12
Trial ID
NCT06870058
Treatments Being Tested
To assess the safety, tolerability and pharmacokinetics of ABT-199 in femal...
Status
Completed
Location
Site Reference ID/Investigator# 89694
Start Date
2012-11
Trial ID
NCT01686555